• About
  • Interesting shortcuts
  • Programmes and Partnerships
    • Search
    • European Partnerships
    • EU-Programme-Call
  • Projects
    • Projects
  • Resources
    • Resources
  • www.decubber.com
    • Login
  • Programmes and Partnerships
  • EU-Programme-Call
  • Horizon 2020
  • H2020-EU.3. SOCIETAL CHALLENGES
  • H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
  • H2020-EU.3.1.0. Cross-cutting call topics

H2020-EU.3.1.0. Cross-cutting call topics

Mapped projects (386)
  • H2020-Adhoc-2014-20
    (10)
    • Health Health
      (10)
  • H2020-HCO-2014
    (4)
    • HCO-14-2014 Bridging the divide in European health research and innovation
      (2)
    • HCO-15-2014 Mobilisation and mutual learning action plan
      (1)
    • HCO-16-2014 National contact points
      (1)
  • H2020-IBA-SC1-BIOMEDICAL-2017
    (1)
    • IBA-SC1-BIOMEDICAL-2017
      (1)
  • H2020-IBA-SC1-CORONAVIRUS-2020-4
    (1)
    • IBA-SC1-CORONAVIRUS-2020-4 EU-wide Covid-19 vaccine trial network
      (1)
  • H2020-IBA-SC1-eHealth-2017
    (1)
    • IBA-SC1-eHealth-2017
      (1)
  • H2020-IBA-SC1-Presidency-2020
    (1)
    • IBA-SC1-Presidency-2020
      (1)
  • H2020-JTI-IMI2-2015-08-single-stage
    (4)
    • IMI2-2015-08-01 Ebola and other filoviral haemorrhagic fevers (Ebola+) programme: future outbreaks
      (4)
  • H2020-JTI-IMI2-2020-20-two-stage
    (6)
    • IMI2-2020-20-01 Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis
      (1)
    • IMI2-2020-20-02 Innovations to accelerate vaccine development vaccine development and manufacture
      (1)
    • IMI2-2020-20-03 Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
      (1)
    • IMI2-2020-20-04 Tumour plasticity
      (1)
    • IMI2-2020-20-05 Proton versus photon therapy for oesophageal cancer - a trimodality strategy
      (1)
    • IMI2-2020-20-06 Handling of protein drug products and stability concerns
      (1)
  • H2020-JTI-IMI2-2020-22-single-stage
    (4)
    • IMI2-2020-22-01 Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities
      (3)
    • SC1-BHC-37-2020 Towards the new generation of clinical trials ? trials methodology research
      (1)
  • H2020-JTI-IMI2-2020-23-two-stage
    (6)
    • IMI2-2020-23-01 Returning Clinical Trial Data to study participants within a GDPR compliant and approved ethical framework
      (1)
    • IMI2-2020-23-02 Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistance
      (1)
    • IMI2-2020-23-03 A platform for accelerating biomarker discovery and validation to support therapeutics development for neurodegenerative diseases
      (1)
    • IMI2-2020-23-04 Optimal treatment for patients with solid tumours in Europe through Artificial Intelligence
      (1)
    • IMI2-2020-23-05 Shortening the path to Rare Disease diagnosis by using newborn genetic screening and digital technologies
      (1)
    • IMI2-2020-23-06 Behavioural Model of Factors Affecting Patient Adherence
      (1)
  • H2020-PHC-2014-single-stage
    (19)
    • PHC-20-2014 Advancing active and healthy ageing with ICT: ICT solutions for independent living with cognitive impairment
      (5)
    • PHC-26-2014 Self management of health and disease: citizen engagement and mHealth
      (14)
  • H2020-SC1-2020-Single-Stage-RTD
    (46)
    • SC1-BHC-06-2020 Digital diagnostics ? developing tools for supporting clinical decisions by integrating various diagnostic data
      (5)
    • SC1-BHC-11-2020 Advancing the safety assessment of chemicals without the use of animal testing
      (3)
    • SC1-BHC-17-2020 Global Alliance for Chronic Diseases (GACD) - Prevention and/or early diagnosis of cancer
      (6)
    • SC1-BHC-20A-2020 Pre-commercial procurement (PCP) for integrated care solutions
      (4)
    • SC1-BHC-33-2020 Addressing low vaccine uptake
      (3)
    • SC1-BHC-34-2020 New approaches for clinical management and prevention of resistant bacterial infections in high prevalence settings
      (2)
    • SC1-BHC-35-2020 Creation of a European wide sustainable network for harmonised large-scale clinical research studies for infectious diseases
      (1)
    • SC1-BHC-36-2020 Micro- and nano-plastics in our environment: Understanding exposures and impacts on human health
      (5)
    • SC1-DTH-12-2020 Use of Real-World Data to advance research on the management of complex chronic conditions
      (7)
    • SC1-HCC-10-2020 Towards a Health research and innovation Cloud: Capitalising on data sharing initiatives in health research
      (1)
    • SC1-HCO-03-2020 Bridging the divide in health research and innovation ? boosting return on investment
      (1)
    • SC1-HCO-07-2020 ERA-NET to support the Joint Programming Initiative on Antimicrobial resistance (JPIAMR)
      (1)
    • SC1-HCO-14-2020 ERA-NET: Sustained collaboration of national and regional programmes in cancer research
      (1)
    • SC1-HCO-16-2020 ERA-NET: Sustained collaboration of national and regional programmes in research on brain-related diseases and disorders of the nervous system
      (1)
    • SC1-HCO-17-2020 Coordinating and supporting research on the human microbiome in Europe and beyond
      (1)
    • SC1-HCO-18-2020 Developing methodological approaches for improved clinical investigation and evaluation of high-risk medical devices
      (1)
    • SC1-HCO-19-2020 Reliable and accessible information on cell and gene-based therapies
      (1)
    • SC1-HCO-20-2020 Coordination of clinical research activities of the European Reference Networks
      (1)
    • SGA-SC1-CEPI-2020 Grant to the Coalition for Epidemic Preparedness Innovations (CEPI)
      (1)
  • H2020-SC1-2020-Two-Stage-RTD
    (16)
    • SC1-BHC-24-2020 Healthcare interventions for the management of the elderly multimorbid patient
      (6)
    • SC1-BHC-24-2020 Healthcare interventions for the management of the elderly multimorbid patient
      (6)
    • SC1-BHC-29-2020 Innovative actions for improving urban health and wellbeing - addressing environment, climate and socioeconomic factors
      (6)
    • SC1-DTH-13-2020 Implementation research for scaling up and transfer of innovative solutions involving digital tools for people-centred care
      (4)
    • SC1-DTH-13-2020 Implementation research for scaling up and transfer of innovative solutions involving digital tools for people-centred care
      (4)
  • H2020-SC1-DTH-2020-1
    (16)
    • SC1-DTH-02-2020 Personalised early risk prediction, prevention and intervention based on Artificial Intelligence and Big Data technologies
      (7)
    • SC1-DTH-04-2020 International cooperation in smart living environments for ageing people
      (2)
    • SC1-DTH-06-2020 Accelerating the uptake of computer simulations for testing medicines and medical devices
      (4)
    • SC1-DTH-14-2020 Pre-commercial Procurement for Digital Health and Care Solutions
      (1)
    • SC1-HCC-08-2020 Scaling up innovation for active and healthy ageing
      (1)
    • SC1-HCC-09-2020 Supporting deployment of eHealth in low and lower middle income countries in Africa for better health outcomes
      (1)
  • H2020-SC1-FA-DTS-2020-1
    (4)
    • DT-TDS-04-2020 AI for Genomics and Personalised Medicine
      (4)
  • H2020-SC1-PHE-CORONAVIRUS-2020-2-CNECT
    (13)
    • SC1-PHE-CORONAVIRUS-2020-2B
      (13)
  • H2020-SC1-PHE-CORONAVIRUS-2020-2-RTD
    (19)
    • SC1-BHC-08-2020 New interventions for Non-Communicable Diseases
      (12)
    • SC1-PHE-CORONAVIRUS-2020-2C Behavioural, social and economic impacts of the outbreak response
      (5)
    • SC1-PHE-CORONAVIRUS-2020-2D Pan-European COVID-19 cohorts
      (1)
    • SC1-PHE-CORONAVIRUS-2020-2E Networking of existing EU and international cohorts of relevance to COVID-19
      (1)
  • H2020-SMEINST-1-2014
    (77)
    • PHC-12-2014-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices
      (77)
  • H2020-SMEINST-2-2014
    (19)
    • PHC-12-2014 Clinical research for the validation of biomarkers and/or diagnostic medical devices
      (19)
  • H2020-SMEINST-2-2015
    (12)
    • PHC-12-2015 Clinical research for the validation of biomarkers and/or diagnostic medical devices
      (12)
  • H2020-SMEINST-2-2016-2017
    (107)
    • SMEInst-05-2016-2017 Supporting innovative SMEs in the healthcare biotechnology sector
      (107)
Powered by Chris Decubber BV